693 related articles for article (PubMed ID: 9774218)
1. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
2. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Romero L; Artigas F
J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
[TBL] [Abstract][Full Text] [Related]
3. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
Li XM; Perry KW; Wong DT
Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
[TBL] [Abstract][Full Text] [Related]
4. Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei.
Hopwood SE; Stamford JA
Neuropharmacology; 2001 Mar; 40(4):508-19. PubMed ID: 11249960
[TBL] [Abstract][Full Text] [Related]
5. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T; Umbers V; Gartside SE
Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
[TBL] [Abstract][Full Text] [Related]
6. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat.
Hervás I; Queiroz CM; Adell A; Artigas F
Br J Pharmacol; 2000 May; 130(1):160-6. PubMed ID: 10781012
[TBL] [Abstract][Full Text] [Related]
7. The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig.
Roberts C; Price GW; Jones BJ
Eur J Pharmacol; 1997 May; 326(1):23-30. PubMed ID: 9178651
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
Hervás I; Artigas F
Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
[TBL] [Abstract][Full Text] [Related]
9. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP
Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809
[TBL] [Abstract][Full Text] [Related]
10. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
Knobelman DA; Hen R; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805
[TBL] [Abstract][Full Text] [Related]
11. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
12. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions.
Roberts C; Belenguer A; Middlemiss DN; Routledge C
Eur J Pharmacol; 1998 Apr; 346(2-3):175-80. PubMed ID: 9652357
[TBL] [Abstract][Full Text] [Related]
14. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis.
McQuade R; Sharp T
J Neurochem; 1997 Aug; 69(2):791-6. PubMed ID: 9231740
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin.
Tao R; Ma Z; Auerbach SB
J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus.
Dudley TE; Dinardo LA; Glass JD
J Neurophysiol; 1999 Apr; 81(4):1469-77. PubMed ID: 10200183
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
Roberts C; Boyd DF; Middlemiss DN; Routledge C
Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
[TBL] [Abstract][Full Text] [Related]
18. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation.
Rutter JJ; Gundlah C; Auerbach SB
Synapse; 1995 Jul; 20(3):225-33. PubMed ID: 7570354
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors.
Pallotta M; Segieth J; Whitton PS
Brain Res; 1998 Feb; 783(2):173-8. PubMed ID: 9507110
[TBL] [Abstract][Full Text] [Related]
20. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice.
Evrard A; Malagié I; Laporte AM; Boni C; Hanoun N; Trillat AC; Seif I; De Maeyer E; Gardier A; Hamon M; Adrien J
Eur J Neurosci; 2002 Mar; 15(5):841-51. PubMed ID: 11906526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
